Top compounds associated with response to EHD2


Feature Type Standardized
Nominal ANOVA
mRNA SB-743921 CTRPv2 pan-cancer AAC -0.2 5e-08
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.21 6e-08
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.2 8e-08
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.2 1e-07
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.2 2e-07
mRNA KPT185 CTRPv2 pan-cancer AAC -0.22 2e-07
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 2e-07
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.21 3e-07
mRNA PF-562271 GDSC1000 pan-cancer AAC 0.19 3e-07
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.18 3e-07
Download CSV